PHUNWARE INC (PHUN) Fundamental Analysis & Valuation

NASDAQ:PHUN • US71948P2092

1.69 USD
-0.07 (-3.98%)
At close: Mar 6, 2026
1.65 USD
-0.04 (-2.37%)
Pre-Market: 3/9/2026, 4:03:00 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PHUN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall PHUN gets a fundamental rating of 3 out of 10. We evaluated PHUN against 277 industry peers in the Software industry. PHUN has a great financial health rating, but its profitability evaluates not so good. PHUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. PHUN Profitability Analysis

1.1 Basic Checks

  • PHUN had negative earnings in the past year.
  • In the past year PHUN has reported a negative cash flow from operations.
  • In the past 5 years PHUN always reported negative net income.
  • PHUN had a negative operating cash flow in each of the past 5 years.
PHUN Yearly Net Income VS EBIT VS OCF VS FCFPHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • PHUN's Return On Assets of -11.27% is on the low side compared to the rest of the industry. PHUN is outperformed by 63.54% of its industry peers.
  • PHUN has a Return On Equity (-12.11%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -11.27%
ROE -12.11%
ROIC N/A
ROA(3y)-295.45%
ROA(5y)-202%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PHUN Yearly ROA, ROE, ROICPHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

  • PHUN has a worse Gross Margin (41.32%) than 75.45% of its industry peers.
  • PHUN's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for PHUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.33%
GM growth 5Y-2.93%
PHUN Yearly Profit, Operating, Gross MarginsPHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PHUN Health Analysis

2.1 Basic Checks

  • PHUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PHUN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PHUN has been increased compared to 5 years ago.
  • There is no outstanding debt for PHUN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHUN Yearly Shares OutstandingPHUN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
PHUN Yearly Total Debt VS Total AssetsPHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • PHUN has an Altman-Z score of -0.91. This is a bad value and indicates that PHUN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.91, PHUN is not doing good in the industry: 75.45% of the companies in the same industry are doing better.
  • PHUN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.91
ROIC/WACCN/A
WACC12.24%
PHUN Yearly LT Debt VS Equity VS FCFPHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 17.03 indicates that PHUN has no problem at all paying its short term obligations.
  • The Current ratio of PHUN (17.03) is better than 96.75% of its industry peers.
  • PHUN has a Quick Ratio of 17.03. This indicates that PHUN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 17.03, PHUN belongs to the best of the industry, outperforming 96.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.03
Quick Ratio 17.03
PHUN Yearly Current Assets VS Current LiabilitesPHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. PHUN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.58% over the past year.
  • PHUN shows a strong growth in Revenue. In the last year, the Revenue has grown by 1314.95%.
  • PHUN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.13% yearly.
EPS 1Y (TTM)90.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52%
Revenue 1Y (TTM)1314.95%
Revenue growth 3Y-33.08%
Revenue growth 5Y-30.13%
Sales Q2Q%-6.47%

3.2 Future

  • PHUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.31% yearly.
  • The Revenue is expected to grow by 14.73% on average over the next years. This is quite good.
EPS Next Y36.78%
EPS Next 2Y20.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.82%
Revenue Next 2Y14.73%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHUN Yearly Revenue VS EstimatesPHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PHUN Yearly EPS VS EstimatesPHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. PHUN Valuation Analysis

4.1 Price/Earnings Ratio

  • PHUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PHUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHUN Price Earnings VS Forward Price EarningsPHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHUN Per share dataPHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PHUN's earnings are expected to grow with 20.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHUN Dividend Analysis

5.1 Amount

  • No dividends for PHUN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHUN Fundamentals: All Metrics, Ratios and Statistics

PHUNWARE INC

NASDAQ:PHUN (3/6/2026, 8:00:00 PM)

Premarket: 1.65 -0.04 (-2.37%)

1.69

-0.07 (-3.98%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06
Earnings (Next)03-18
Inst Owners13.96%
Inst Owner Change13.85%
Ins Owners0.29%
Ins Owner Change0%
Market Cap34.12M
Revenue(TTM)2.36M
Net Income(TTM)-11.91M
Analysts80
Price Target6.29 (272.19%)
Short Float %3.54%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.5%
Min EPS beat(2)-4.58%
Max EPS beat(2)21.57%
EPS beat(4)2
Avg EPS beat(4)11.21%
Min EPS beat(4)-41.18%
Max EPS beat(4)69.04%
EPS beat(8)5
Avg EPS beat(8)-4.16%
EPS beat(12)7
Avg EPS beat(12)-15.24%
EPS beat(16)7
Avg EPS beat(16)-98.56%
Revenue beat(2)1
Avg Revenue beat(2)-16.23%
Min Revenue beat(2)-38.6%
Max Revenue beat(2)6.15%
Revenue beat(4)1
Avg Revenue beat(4)-17.5%
Min Revenue beat(4)-38.6%
Max Revenue beat(4)6.15%
Revenue beat(8)1
Avg Revenue beat(8)-23.81%
Revenue beat(12)1
Avg Revenue beat(12)-45.71%
Revenue beat(16)3
Avg Revenue beat(16)-35.15%
PT rev (1m)0%
PT rev (3m)7.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10%
EPS NY rev (1m)0%
EPS NY rev (3m)5.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.48
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.12
BVpS4.87
TBVpS4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.27%
ROE -12.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.32%
FCFM N/A
ROA(3y)-295.45%
ROA(5y)-202%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.33%
GM growth 5Y-2.93%
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.03
Quick Ratio 17.03
Altman-Z -0.91
F-Score5
WACC12.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52%
EPS Next Y36.78%
EPS Next 2Y20.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1314.95%
Revenue growth 3Y-33.08%
Revenue growth 5Y-30.13%
Sales Q2Q%-6.47%
Revenue Next Year-32.82%
Revenue Next 2Y14.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-89.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-36.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.64%
OCF growth 3YN/A
OCF growth 5YN/A

PHUNWARE INC / PHUN FAQ

Can you provide the ChartMill fundamental rating for PHUNWARE INC?

ChartMill assigns a fundamental rating of 3 / 10 to PHUN.


What is the valuation status for PHUN stock?

ChartMill assigns a valuation rating of 1 / 10 to PHUNWARE INC (PHUN). This can be considered as Overvalued.


What is the profitability of PHUN stock?

PHUNWARE INC (PHUN) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for PHUN stock?

The Earnings per Share (EPS) of PHUNWARE INC (PHUN) is expected to grow by 36.78% in the next year.